Cerebrovascular diseases including cerebral amyloid angiopathy (CAA) and atherosclerosis often co-present with AD (3–5), and reduced cerebral blood flow in the human AD brain is associated with both cognitive decline (6, 7) and tau accumulation (8–10). This evidence concerns the gene MAPT and Alzheimer disease.